Literature DB >> 7635958

Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization.

T Abe1, K Takeuchi, N Takahashi, E Tsutsumi, Y Taniyama, K Abe.   

Abstract

Thromboxane (TX) plays important roles in control of renal hemodynamics and water and electrolyte metabolism, and is involved in the pathophysiology of many renal diseases. The aim of the present study is to isolate a rat kidney cDNA encoding functional TX receptor, and to reveal its intrarenal expression localization. A clone (rTXR2) was isolated from a rat kidney cDNA library by a homology screening approach. rTXR2 was shown to encode the amino acid sequence containing seven transmembrane spanning domains representing rat (r) TX receptor. The membrane from COS-7 cells transiently transfected with rTXR2 cDNA was shown to be specifically bound by a thromboxane receptor antagonist, SQ29548. Either in Xenopus oocyte expression or in transfected COS-7 cells, rTX receptor was shown to be linked with Ca2+ messenger system. TX receptor-mediated increase in cytosolic Ca2+ was also observed in cultured glomerular mesangial cells. In situ hybridization showed that rTX receptor mRNA was detected in renal glomeruli, smooth muscle cells in renal arterioles, and transitional cell epithelium of renal pelvis. Reverse transcription linked to PCR applied to microdissected nephron segments indicated the presence of rTX receptor mRNA exclusively in the glomerulus. In conclusion, we have cloned a functional rat kidney TX receptor, which is expressed specifically in renal glomerulus, arterial smooth muscle cells, and transitional cell epithelium of renal pelvis. The present study will provide important insights into the etiology and pathophysiology of renal diseases with relation to TX metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635958      PMCID: PMC185246          DOI: 10.1172/JCI118108

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.

Authors:  I Miki; H Kase; A Ishii
Journal:  Eur J Pharmacol       Date:  1992-10-01       Impact factor: 4.432

Review 2.  Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction.

Authors:  A M Spiegel; A Shenker; L S Weinstein
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

3.  Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.

Authors:  I Miki; N Kishibayashi; H Nonaka; E Ohshima; H Takami; H Obase; A Ishii
Journal:  Jpn J Pharmacol       Date:  1992-07

4.  A rat model of progressive chronic glomerular sclerosis: the role of thromboxane inhibition.

Authors:  R A Stahl; F Thaiss; U Wenzel; W Schoeppe; U Helmchen
Journal:  J Am Soc Nephrol       Date:  1992-05       Impact factor: 10.121

5.  Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa.

Authors:  W J Welch; C S Wilcox
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Thromboxane receptor blockade reduces renal injury in murine lupus nephritis.

Authors:  R F Spurney; P Y Fan; P Ruiz; F Sanfilippo; D S Pisetsky; T M Coffman
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

7.  Thromboxane receptor blockade attenuates chronic cyclosporine nephrotoxicity and improves survival in rats with renal isograft.

Authors:  N Perico; M Rossini; O Imberti; B Malanchini; R P Cornejo; F Gaspari; T Bertani; G Remuzzi
Journal:  J Am Soc Nephrol       Date:  1992-03       Impact factor: 10.121

8.  Phosphoinositide hydrolysis and calcium mobilization induced by vasopressin and angiotensin II in cultured vascular smooth muscle cells.

Authors:  K Takeuchi; K Abe; M Yasujima; M Sato; K Maeyama; T Watanabe; S Sato; H Inaba; K Yoshinaga
Journal:  Tohoku J Exp Med       Date:  1992-01       Impact factor: 1.848

9.  Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.

Authors:  W H Folger; P V Halushka; C S Wilcox; N J Guzman
Journal:  Eur J Pharmacol       Date:  1992-09-01       Impact factor: 4.432

Review 10.  Eicosanoids, mesangial contraction, and intracellular signal transduction.

Authors:  P Mene'; M S Simonson; M J Dunn
Journal:  Tohoku J Exp Med       Date:  1992-01       Impact factor: 1.848

View more
  8 in total

1.  Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.

Authors:  D W Thomas; R B Mannon; P J Mannon; A Latour; J A Oliver; M Hoffman; O Smithies; B H Koller; T M Coffman
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

2.  Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells.

Authors:  S Karim; E Berrou; S Lévy-Toledano; M Bryckaert; J MacLouf
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor.

Authors:  Leanne P Kelley-Hickie; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

4.  A role for the thromboxane receptor in L-NAME hypertension.

Authors:  Helene Francois; Natalia Makhanova; Philip Ruiz; Jonathan Ellison; Lan Mao; Howard A Rockman; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-06

5.  The implications of aspirin resistance in renal failure.

Authors:  Jecko Thachil
Journal:  NDT Plus       Date:  2008-06

6.  Downregulation of Thromboxane A2 Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery.

Authors:  Yaping Zhang; Man Mi; Yan-Hua Xie; Si-Wang Wang; Lars Edvinsson; Cang-Bao Xu
Journal:  Adv Pharmacol Sci       Date:  2017-07-09

7.  Diverse associations between oxidative stress and thromboxane A2 in hypertensive glomerular injury.

Authors:  Yukihito Nakano; Yoshihisa Nakatani; Masahiro Takami; Yoshihiro Taniyama; Shuji Arima
Journal:  Hypertens Res       Date:  2018-12-13       Impact factor: 3.872

8.  Thromboxane A2 receptor antagonist (ONO-8809) attenuates renal disorders caused by salt overload in stroke-prone spontaneously hypertensive rats.

Authors:  Yusuke Nagatani; Toshihide Higashino; Kosho Kinoshita; Hideaki Higashino
Journal:  Clin Exp Pharmacol Physiol       Date:  2021-07-05       Impact factor: 2.557

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.